Curriculum Vitae

PERSONAL INFORMATION Elisabeth Penninga

WORK EXPERIENCE

September 2012- Present Chief Medical Officer, Specialist i Clinical Pharmacology Danish Medicines Agency () Employed at Department of Medical Evaluation & Biostatistics, working as medical assessor. COMP member from January 2018 -

April 2012-August 2012 Specialist in Clinical Pharmacology Bispebjerg , Copenhagen University Hospital (Denmark) Employed at Department of Clinical Pharmacology.

January 2011-March 2012 Residency training, Department of Clinical Pharmacology Bispebjerg Hospital, Copenhagen Copenhagen University Hospital (Denmark) Employed at Department of Clinical Pharmacology.

January 2010-December 2010 Medical doctor Steno Diabetes Center (Denmark) Working with diabetic patients; out-patient care as well as hospitalised patients.

January 2009-December 2009 Medical doctor Amager Hospital, Copenhagen Copenhagen University Hospital (Denmark) Medical doctor at the Geriatric Department / Department of

January 2008-December 2008 Residency training, Depatment of Clinical Pharmacology Bispebjerg Hospital, Copenhagen Copenhagen University Hospital (Denmark) Working at the Medical Department, Leo Pharma.

January 2006-December 2006 Residency training, Department of Clinical Pharmacology Bispebjerg Hospital, Copenhagen Copenhagen University Hospital (Denmark)

October 2004-December 2004 Medical doctor Hvidovre Hospital, Copenhagen University Hospital (Denmark) Medical doctor at the Department of Neurology.

March 2004-September 2004 Medical doctor, internship General Practitioner (Denmark) Working as a general practitioner

September 2003-February 2004 Medical doctor, internship Herlev Hospital, Copenhagen University Hospital (Denmark) Medical doctor at the Department of Internal Medicine.

March 2003-August 2003 Medical doctor, internship Herlev Hospital, Copenhagen University Hospital (Denmark) Medical doctor at the Department of Urology. EDUCATION AND TRAINING

January 2006-March 2012 Courses of clinical pharmacology Copenhagen University (Denmark) During the specialisation atteded various courses relevant for clinical pharmacology. ADDITIONAL INFORMATION

13/01/2021 European Medicine Agency Page 1/2 Expertise Clinical pharmacology, neurology, diabetology, internal medicine. Publications Tzogani K, Penninga E. et al. EMA Review of Daratumumab for the Treatment of Adult Patients with Multiple Myeloma. Oncologist. 2018 May;23(5):594-602. Penninga EI, Graudal N, Ladekarl MB, Jürgens G. Adverse Events Associated with Flumazenil Treatment for the Management of Suspected Benzodiazepine Intoxication A Systematic Review with Meta-Analyses of Randomised Trials. Basic & Clin Pharmacol Toxicol. Article first published online: 28 JUL 2015. DOI: 10.1111/bcpt.12434. Ranjan A, Penninga EI. et al. Inheritance of the chronic myeloproliferative neoplasms a systematic review. Clin Genet. 2013 Feb;83(2):99-107. Posterpresentation: Relation between drug lipophilicity and effectiveness of intravenous fat emulsion treatment ved European Association of Poisons Centres and Clinical Toxicologists (EAPCCT), London, UK, May 2012. Penninga EI, Jespersen M, Andersen SE. Drug and Therapeutics Committees in Copenhagen, Denmark. TFD-KFÇG E-bulten; Say 58, Nisan 2012. Link: http://www.tfd-kfcg.org/index/default.aspx?id=472 Penninga EI, Færch K. et al. Liraglutids glukose- og vægtreducerende effekt ved behandling af type 2-diabetes. Ugeskr Laeger. 2011 Jun 27;173(26):1863-9. Penninga L, Penninga EI. Appendicitis during pregnancy: systematic review. Int J Med Biol Front 2010:16 Iss 11/12. Penninga L, Penninga EI. Appendicitis during pregnancy: a serious disease and a diagnostic problem in Infectious pregnancy complications. ISBN 978-60471-038-6 Ed: Canfield RN, New York; March 2009. Penninga EI, Dalhoff KP, Lykkegaard SE. Quetiapin induceret leukopeni. Ugeskr Læger, 2008; 170(37):2892. Penninga EI, Larsen HK, Andersen2008 E. Impotens forårsaget af behandling med Methotrexat. Ugeskr for Læger, 2008;170(5):354. Engberg AW, Penninga EI, Teasdale TW. Nordisk ulykkesklassifikation anvendt i Landspatient-registeret til registrering af årsager til hovedtraumer. Ugeskr for Læger, 2007;45: 3856-60. Penninga EI, Bjerrum OW. Polycythaemia vera and essential thrombocythaemia. Current treatment strategies. Drugs, 2006; 66(17):2173-87. Penninga L, Penninga EI. et al. Damage control hos multitraumatiserede patienter. Ugeskr for Læger, 2005;167:3403-7. Penninga EI, Jensen BA. et al. Treatment with Anagrelide in 53 patients. Clinical and Laboratory Haematology, 2004;26:335-40. Penninga EI, Gimsing P. To tilfælde af akromegali koeksisterende med en B-celle-sygdom. Ugeskr for Læger, 2001;163:4594-5. Projects 2011-2013: Tutor for a medical student at Copenhagen University during his research regarding the Inheritance of the chronic myeloproliferative neoplasms. Department of Haematology, Rigshospitalet, Copenhagen University Hospital, Denmark. 2011-2012: Chairman for the local Drugs and Therapeutics Committee, Bispebjerg Hospital, Copenhagen University Hospital, Denmark. 2011-2012: Member of the local Drugs and Therapeutics Committee, Amager Hospital, Copenhagen University Hospita, Denmark. 2006-2008: Teacher in clinical pharmacology, Copenhagen School for Dental Clinic Assistants and Dental Hygienists, Copenhagen, Denmark. Memberships Other Relevant Information

13/01/2021 European Medicine Agency Page 2/2